RBC Capital Markets kept its Outperform rating on Albertsons and held a US$21 price target, citing modest estimate cuts ahead of next week’s results. The research note pointed to softer identical store sales, a measure of revenue at locations open at least a year, and a slightly lower margin outlook.
Albertsons shares were recently trading around US$17, leaving a gap to the target, as investors weigh the path for earnings and capital returns. The action matters in Canada because RBC is a major TSX-listed lender and cross‑border advisor, and its U.S. retail calls often flow through to domestic portfolio positioning. RBC’s latest view was first reported by Investing.com, which said the firm trimmed third quarter forecasts and detailed its valuation work on the grocer.
Price lags target, valuation talk
RBC framed Albertsons’ valuation as attractive versus its cash flow outlook. The bank highlighted the stock’s multiple on projected EBITDA, or earnings before interest, taxes, depreciation and amortization, as a support for the rating. “Very cheap,” RBC wrote, underscoring the spread between the share price and its 2026 model, according to the Investing.com account. The stock remains below that target by a wide margin. For Canadian funds that own U.S. staples, the setup keeps focus on execution, especially around pricing, private label, and retail media.
Ahead of a scheduled earnings update on Jan. 7, RBC is watching for signs that price investments and store productivity can offset mix headwinds from pharmacy. Same store sales near the 2 to 3 per cent range remain the base case in the note, with near‑term margin pressure manageable if promotions drive traffic.
Any clearer line to free cash flow could reopen the door to buybacks or balance sheet moves. That is the operational picture RBC laid out in the latest coverage, as summarized by the Investing.com report on the note.
Deal overhang and what’s next
Regulatory outcomes still shape sentiment. In February 2024, the U.S. Federal Trade Commission said it had “sued to block the largest proposed supermarket merger in U.S. history,” referring to Kroger’s bid for Albertsons, and argued the tie‑up would reduce competition and hurt workers and shoppers.
The court fight led to more setbacks for the transaction through late 2024, and by March 25, 2025, coverage from Reuters described a legal turn to countersuits after the deal was terminated the previous December. That shift left investors refocusing on Albertsons as a standalone operator rather than a merger arbitrage case. For Canadian readers, the antitrust stance in the United States has also coloured expectations for consolidation at home.
RBC’s call now rests on store‑level performance and capital allocation rather than a deal close. The bank’s modelling leans on steady traffic and owned‑brand gains to support margins, with cost control limiting erosion from mix. Execution is the hinge. If progress shows up in January’s numbers, the discount to RBC’s target could narrow, the note suggests, per the Investing.com summary. If not, the share price may continue to trade against the headline risk that has dogged the name since the merger saga.
Albertsons’ operating footprint in pharmacy, fresh, and centre‑store staples gives it defensive traits during slower growth. Still, competitive intensity and wage costs remain watch items into 2026. RBC’s reiteration keeps the spotlight on valuation, cash generation, and stability in core categories. Investors will now look for confirmation in next week’s results and guidance, and whether management signals any changes to capital returns or real estate strategy coming out of the quarterly review.
“RBC Capital kept its Outperform rating and US$21 price target,” the Investing.com report said, while noting the firm’s near‑term caution on sales mix and margins.
The FTC, for its part, described its suit to stop the Kroger tie‑up as necessary to protect competition, a stance that shapes the backdrop Albertsons must now navigate on its own.
